comparemela.com

Latest Breaking News On - Laxai life sciences private limited - Page 1 : comparemela.com

CSIR gets drug regulator s nod for clinical trial of Colchicine on Covid-19 patients

The Drugs Controller General of India has approved the Phase-II trial of Colchicine, which can help Covid-19 patients with co-morbidities related to heart and also for their faster recovery.

Jammu and kashmirAndhra pradeshRam vishwakarmaRam upadhayayShekharc mandeCouncil of scientificCsir indian institute of integrative medicineLaxai life sciencesHyderabad laxai life sciences privateCsir indian institute of chemical technologyIndustrial researchLaxai life sciences private limitedDrugs controller generalIndian instituteChemical technologyIntegrative medicine

DGCI gives regulatory approval for clinical trials of Colchicine, the drug expected to reduce cardiac complications in C

Colchicine has the potential to act as therapeutic intervention for COVID-19 patients with cardiac comorbidities.

India generalJammu and kashmirUnited statesAndhra pradeshRam upadhayayRam vishwakarmaCouncil of scientificLaxai life sciences pvt ltd hyderabadLaxai life sciences privateCsir indian institute of integrative medicineCsir indian institute of chemical technologyIndustrial researchAmit daveHindustan times indiaLaxai life sciences private limitedDrugs controller general

Regulatory nod given to conduct clinical trials of Colchicine: CSIR

Read more about Regulatory nod given to conduct clinical trials of Colchicine: CSIR on Business Standard. The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct clinical trial of Colchicine on COVID-19 patients, according to a statement on Saturday.Ram Vishwakarma, the advisor to

Jammu and kashmirAndhra pradeshRam upadhayayRam vishwakarmaLaxai life sciences pvt ltdLaxai life sciences pvt ltd hyderabadLaxai life sciences privateCsir indian institute of integrative medicineLaxai life sciencesCouncil of scientific industrial researchCsir indian institute of chemical technologyDrugs controller generalLaxai life sciences private limitedIndustrial researchIndian instituteChemical technology

CSIR-Laxai gets DCGI nod for conducting clinical trials of Colchicine on COVID-19 patients

The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct a clinical trial of Colchicine on COVID-19 patients.

Jammu and kashmirAndhra pradeshNew delhiRam vishwakarmaRam upadhayayLaxai life sciences pvt ltdLaxai life sciences pvt ltd hyderabadLaxai life sciences privateCsir indian institute of integrative medicineLaxai life sciencesCouncil of scientific industrial researchCsir indian institute of chemical technologyDrugs controller generalLaxai life sciences private limitedIndustrial researchIndian institute

Coronavirus news LIVE Updates: UP, MP, Gujarat hiding COVID-19 death data, alleges Congress; seeks CMs resignations

Coronavirus news LIVE Updates: Maharashtra records 10,607 new cases, 733 in Mumbai; state s tally reaches 58,98,550 Firstpost 37 minutes ago FP Staff © Provided by Firstpost Coronavirus news LIVE Updates: Maharashtra records 10,607 new cases, 733 in Mumbai; state s tally reaches 58,98,550 21:12 (IST) PGIMER Chandigarh to conduct sero survey of people below 18 years A sero survey of people below 18 years of age will be conducted in Chandigarh to determine the number of children infected by COVID-19, PGIMER director Jagat Ram said on Saturday. Sero surveys or sero prevalence studies are based on analysis of antibodies collected through blood samples. The Post Graduate Institute of Medical Education & Research (PGIMER) has decided to take a sample size of 2,500 Chandigarh-based people below 18 years of age for the survey and the sampling will be done from the city, rural and slum areas,he said.

Tamil naduSaudi arabiaJammu and kashmirSouth africaWest kamengArunachal pradeshMadhya pradeshUnited statesUnited kingdomUttar pradeshEast siangCarbis bayAndhra pradeshSouth koreaEast kamengIndia general

vimarsana © 2020. All Rights Reserved.